Arsenic Trioxide: all 118 studies that test it
Page 2 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Arsenic Trioxide in Treating Patients With Urothelial CancerCompletedNCT00009867Phase 2
- Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic LeukemiaCompletedNCT00008697Phase 1/2
- Arsenic Trioxide for Induction Therapy of Adult Patients With LeukemiaTerminatedNCT00006092Phase 2
- Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous TreatmentWithdrawnNCT00006091Phase 2
- Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic LeukemiaWithdrawnNCT00006090Phase 2
- Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple MyelomaCompletedNCT00006021Phase 1/2
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00006008Phase 2
- Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical CancerCompletedNCT00005999Phase 2
- Arsenic Trioxide in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00005795Phase 2
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or LeukemiaTerminatedNCT00005786Not applicable
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous LeukemiaCompletedNCT00005618Phase 2
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's DiseaseTerminatedNCT00005595Phase 2
- Arsenic Trioxide in Treating Patients With Metastatic Kidney CancerCompletedNCT00005069Phase 2
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaCompletedNCT00005040Phase 2
- Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone TherapyCompletedNCT00004149Phase 2
- Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaStatus unknownNCT00003885Phase 2
- Arsenic Trioxide in Treating Patients With Advanced Solid TumorsCompletedNCT00003630Phase 1
- Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1